Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors

NCT00115128 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT00115128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00115128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Trial of Peripheral Blood Progenitor Cell (PBPC) Mobilization by Filgrastim in Normal Donors
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
November 30, 2003
Completion date
September 30, 2007
Enrollment
309 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

normal pbpc donors